Low dose methotrexate and bone marrow suppression
Authors:
Abstract
Bone marrow suppression can occur even with low doses of methotrexate Methotrexate is an antimetabolite that, apart from its use in malignant disorders, is taken orally in low doses for the control of conditions such as rheumatoid arthritis and psoriasis. When used in chemotherapy it causes profound suppression of bone marrow. However, even at a low dose it may be associated with bone marrow suppression—particularly in the presence of renal insufficiency or when other drugs are taken concomitantly (box 1). Its unusual weekly dosing regimen can result in dose error by patients or clinicians. We present three cases of bone marrow suppression in patients taking low dose methotrexate who presented at a district general hospital during a period of four years (table). View this table: Details of patients with bone marrow suppression after taking methotrexate ### Case 1 A 78 year old woman with rheumatoid arthritis had been taking a weekly dose of 17.5 mg of methotrexate for two months. Before this the dose had been gradually built up over several years. She was admitted with breathlessness and found to be pancytopenic (haemoglobin concentration 100 g/l, white cell count 3.0 × 109/l, neutrophils 2.5 × 109/l, platelets 13 × 109/l). A month earlier her full blood count had been normal. Methotrexate treatment was discontinued. She was treated with intravenous folinic acid and antibiotics and was given transfusions of blood products. Her blood count showed recovery (haemoglobin concentration 137 g/l, white …Keywords
This publication has 11 references indexed in Scilit:
- Methotrexate and mortality in patients with rheumatoid arthritis: a prospective studyThe Lancet, 2002
- Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practiceQJM: An International Journal of Medicine, 2001
- Safety of low dose methotrexate in elderly patients with rheumatoid arthritis2000
- Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?Rheumatology, 2000
- METHOTREXATE USE IN RHEUMATOID ARTHRITISRheumatic Disease Clinics of North America, 1997
- Low dose methotrexate therapy--toxic if not taken correctly. Adverse Drug Reactions Advisory Committee.1994
- Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritisClinical Rheumatology, 1993
- Errors in Prescribing Methotrexate1992
- Americans With Disabilities ActJAMA, 1992
- Haemopoietic toxicity and low‐dose methotrexateMedical Journal of Australia, 1992